GB1174302A - Dihydro-Pyrimidine Derivatives - Google Patents

Dihydro-Pyrimidine Derivatives

Info

Publication number
GB1174302A
GB1174302A GB2722469A GB2722469A GB1174302A GB 1174302 A GB1174302 A GB 1174302A GB 2722469 A GB2722469 A GB 2722469A GB 2722469 A GB2722469 A GB 2722469A GB 1174302 A GB1174302 A GB 1174302A
Authority
GB
United Kingdom
Prior art keywords
compositions
antihypertensive
alkyl
blocking agents
dihydro
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
GB2722469A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Pharmacia and Upjohn Co
Original Assignee
Upjohn Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Upjohn Co filed Critical Upjohn Co
Publication of GB1174302A publication Critical patent/GB1174302A/en
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/46—Two or more oxygen, sulphur or nitrogen atoms
    • C07D239/47—One nitrogen atom and one oxygen or sulfur atom, e.g. cytosine
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/46—Two or more oxygen, sulphur or nitrogen atoms
    • C07D239/48—Two nitrogen atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

1,174,302. Antihypertensive &c. compositions. UPJOHN CO. 31 Jan., 1967 [21 Feb., 1966], No. 27224/69. Divided out of 1,174,301. Heading A5B. [Also in Division C2] Pharmaceutical compositions having antihypertensive, antiviral, antifertiliny, anti-inflammatory and central nervous system stimulant activity, for oral or parenteral administration, comprise a compound of formula: in which R, is C 1-8 alkyl, R 7 is hydrogen, C 1-8 alkyl, bromine or chlorine and n is 0, 1, 2 or 3, or an acid addition salt thereof, together with a carrier. The compositions may also contain other antihypertensives, diuretics, sympathetic blocking agents, ganglion-blocking agents, peripheral vasodilators, reserpinoids, tranquilizers, sedatives, muscle relaxants and anti-histamines; specific examples of such agent are given.
GB2722469A 1966-02-21 1967-01-31 Dihydro-Pyrimidine Derivatives Expired GB1174302A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US52779066A 1966-02-21 1966-02-21

Publications (1)

Publication Number Publication Date
GB1174302A true GB1174302A (en) 1969-12-17

Family

ID=24102929

Family Applications (2)

Application Number Title Priority Date Filing Date
GB472467A Expired GB1174301A (en) 1966-02-21 1967-01-31 Pyrimidine Derivatives
GB2722469A Expired GB1174302A (en) 1966-02-21 1967-01-31 Dihydro-Pyrimidine Derivatives

Family Applications Before (1)

Application Number Title Priority Date Filing Date
GB472467A Expired GB1174301A (en) 1966-02-21 1967-01-31 Pyrimidine Derivatives

Country Status (1)

Country Link
GB (2) GB1174301A (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2207352A (en) * 1987-07-27 1989-02-01 Adolfo Turano Anti-viral pharmaceutical compositions

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2207352A (en) * 1987-07-27 1989-02-01 Adolfo Turano Anti-viral pharmaceutical compositions
GB2207352B (en) * 1987-07-27 1991-05-15 Adolfo Turano Use of papaverine in formulating anti-viral compositions

Also Published As

Publication number Publication date
GB1174301A (en) 1969-12-17

Similar Documents

Publication Publication Date Title
GB1277132A (en) Pyridobenzo-diazepine derivatives
GB1314903A (en) Quinazoline derivatives
GB1180766A (en) 2-Arylamine-1,3-Diazacycloalkenes-(2) and the Preparation Thereof
GB1205957A (en) Pharmaceutical compositions comprising 1-pnenoxy-2-aminopropanes
GB1260848A (en) Propanolamine derivatives
GB1321509A (en) Azepine derivatives
ES468170A1 (en) 14-Amino derivatives of morphine, methods of making them and analgesic compositions containing them
GB1174302A (en) Dihydro-Pyrimidine Derivatives
GB1195199A (en) Improvements in Compositions comprising Insulin.
GB1256723A (en)
GB1365176A (en) Benzodiazepine derivatives
GB1512771A (en) Piperazinyluracil salt
GB1165925A (en) 0,2-Dihydro-1-Hydroxy-4-Phenoxypyrimidines
GB1187546A (en) Propanolamine derivatives
GB1348449A (en) Benzodiazepine derivatives
GB1299421A (en) 3-substituted amino-6-hydrazino-pyridazines
GB1050565A (en)
GB1309868A (en) Benzodiazepine derivativers and a aprocess for the manufacture thereof
GB1323591A (en) Benzodiazepine derivatives
GB1034872A (en) Benzodiazepine derivatives
GB1132397A (en) Improvements in or relating to fluorene derivatives and the manufacture thereof
ES334300A1 (en) A process for the manufacture of benzdiaz[1,4]epine derivatives
GB1503479A (en) Trazino benzodiazepines
GB1391081A (en) Optically active benzodiazepines
GB1190680A (en) Halocinnamoyl Piperidines and Morpholines and Pharmaceutical Compositions Containing Them

Legal Events

Date Code Title Description
PS Patent sealed
PCNP Patent ceased through non-payment of renewal fee